Brokerages Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) PT at $162.00
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-two analysts that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The average 1 year […]
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-two analysts that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The average 1 year […]
